NPACT- Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
NPACT
Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase
Home
Browse
Search
Advance Search
Data Submission
Compound:
Alpha-mangostin
Targets
Gene Name
Gene ID
Cancer
Cell Lines
IC
50
ED
50
EC
50
GI
50
Remark
References
CASP3
caspase 3, apoptosis-related cysteine peptidase
836
Mouse mammary carcinoma
BJMC3879luc2
-
-
-
-
Significantly elevated caspase-3 activity was observed in BJMC3879luc2 cells treated with alpha-mangostin for 24 hour.
21639868
CASP3
caspase 3, apoptosis-related cysteine peptidase
836
Breast Carcinoma
MDA-MB-231
-
-
-
-
Significantly elevated caspase-3, activity was observed in MDA-MB231 cells treated with alpha-mangostin for 24 h.
22577295
CASP8
caspase 8, apoptosis-related cysteine peptidase
841
Mouse mammary carcinoma
BJMC3879luc2
-
-
-
-
Significantly elevated caspase-8 activity was observed in BJMC3879luc2 cells treated with alpha-mangostin for 24 hour.
21639868
CASP8
caspase 8, apoptosis-related cysteine peptidase
841
Breast Carcinoma
MDA-MB-231
-
-
-
-
Significantly elevated caspase-8 activity was observed in MDA-MB231 cells treated with alpha-mangostin for 24 h.
22577295
CASP9
caspase 9, apoptosis-related cysteine peptidase
842
Mouse mammary carcinoma
BJMC3879luc2
-
-
-
-
Significantly elevated caspase-9 activity was observed in BJMC3879luc2 cells treated with alpha-mangostin for 24 hour.
21639868
CASP9
caspase 9, apoptosis-related cysteine peptidase
842
Breast Carcinoma
MDA-MB-231
-
-
-
-
Significantly elevated caspase-9 activity was observed in MDA-MB231 cells treated with alpha-mangostin for 24 h.
22577295
CCND1
cyclin D1
595
Breast Carcinoma
MDA-MB-231
-
-
-
-
On Western blotting analysis, cyclin D1 (36 kDa) protein was significantly lower with alpha-mangostin for 24 h, as compared to controls.
22577295
CDK2
cyclin-dependent kinase 2
1017
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the expression of p21cip1 was up-regulated and CHEK2 expression tended to increase for more than 6 h after alpha-mangostin treatment. p21cip1 is a cyclin dependent kinase inhibitor and the encoded protein binds to and inhibits the activity of cyclin-CDK2 (CDK: cyclindependent kinase.
22577295
CDK4
cyclin-dependent kinase 4
1019
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the expression of p21cip1 was up-regulated and CHEK2 expression tended to increase for more than 6 h after alpha-mangostin treatment. p21cip1 is a cyclin dependent kinase inhibitor and the encoded protein binds to and inhibits the activity of cyclin-CDK2 (CDK: cyclindependent kinase.
22577295
CDK6
cyclin-dependent kinase 6
1021
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the expression of p21cip1 was up-regulated and CHEK2 expression tended to increase for more than 6 h after alpha-mangostin treatment. p21cip1 is a cyclin dependent kinase inhibitor and the encoded protein binds to and inhibits the activity of cyclin-CDK2 (CDK: cyclindependent kinase.
22577295
CDK7
cyclin-dependent kinase 7
1022
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the expression of p21cip1 was up-regulated and CHEK2 expression tended to increase for more than 6 h after alpha-mangostin treatment. p21cip1 is a cyclin dependent kinase inhibitor and the encoded protein binds to and inhibits the activity of cyclin-CDK2 (CDK: cyclindependent kinase.
22577295
CDKN1A
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
1026
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the expression of p21cip1 was up-regulated and CHEK2 expression tended to increase for more than 6 h after alpha-mangostin treatment.
22577295
CHEK-2
checkpoint kinase 2
11200
Breast Carcinoma
MDA-MB-231
-
-
-
-
Real-time analysis revealed that the CHEK2 expression tended to increase for more than 6h after a-mangostin treatment
22577295
CYCS
cytochrome c
54205
Breast Carcinoma
MDA-MB-231
-
-
-
-
In order to confirm mitochondria-mediated apoptosis, levels of cytochrome c were measured by flow cytometry and Western blot. The levels of cytochrome c protein in mitochondrial fractions were significantly lower in cells treated with alpha-mangostin for 24 .
22577295
CYCS
cytochrome c
54205
Mouse mammary carcinoma
BJMC3879luc2
-
-
-
-
The levels of cytochrome c protein in cytosolic fractions were significantly higher in cells treated with alpha-mangostin alone for 24 hour, strongly suggesting the engagement of the mitochondria-mediated apoptotic pathway.
21639868
MAPK7
mitogen-activated protein kinase 7
5598
Colon Adenocarcinoma
DLD-1
-
-
-
-
Human colon cancer cells showed that alpha-mangostin inhibited Erk5 phosphorylation involving the mitogen-activated protein kinase (MAPK) signaling pathway.
19325754
PCNA
proliferating cell nuclear antigen
5111
Breast Carcinoma
MDA-MB-231
-
-
-
-
On Western blotting analysis, PCNA (36 kDa) was significantly lower, in cells treated with alpha-mangostin for 24 h, as compared to controls.
22577295
Help
FAQs
Statistics
Tool
Contact
Copyright © 2012. Subhash M. Agagrwal. All Rights Reserved.